Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Selenium
AddedFeb 15, 2024
UpdatedJun 18, 2026
Selenium

Selenium

Pre-Seed

Selenium Ltd: A biopharmaceutical company providing selenium-based therapeutic drugs and device coatings.

HQ
Austin, TX, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

Founded in Austin, Texas, Selenium Ltd is a biopharmaceutical company dedicated to leveraging selenium-based technology to develop therapeutic drugs and medical device coatings. The company's core mission is to improve patient outcomes through innovative and effective treatments. Selenium Ltd focuses on creating advanced solutions for both the healthcare and industrial sectors, aiming to address unmet medical needs and enhance the performance of medical devices.

Selenium Ltd has garnered attention from notable investors in the biopharmaceutical industry and has established partnerships with leading healthcare institutions. The company has achieved significant milestones, including the successful development and commercialization of several selenium-based therapeutic products. Selenium Ltd's impact is evident in its contributions to advancing medical treatments and improving the quality of life for patients worldwide.

Selenium - Similar Companies

Selva Therapeutics logo

Selva Therapeutics

Silk Technologies logo

Silk Technologies

silk-tech.com

Spheringenics logo

Spheringenics

Sequella logo

Sequella

Soltego logo

Soltego

soltego.com

Seelos Therapeutics logo

Seelos Therapeutics

Soleno Therapeutics logo

Soleno Therapeutics

soleno.life

Sealonix logo

Sealonix

sealonix.com

Biosenix logo

Biosenix

Selonterra logo

Selonterra

selonterra.com

Serenus Biotherapeutics logo

Serenus Biotherapeutics

Seneca Therapeutics logo

Seneca Therapeutics

SphynKx Therapeutics logo

SphynKx Therapeutics

Secura Bio logo

Secura Bio

securabio.com

Blade Therapeutics logo

Blade Therapeutics

Selenium - Quick Facts

Who are Selenium's competitors?

Companies similar to Selenium include Selva Therapeutics, Silk Technologies, Spheringenics and Sequella.

When was Selenium founded?

Selenium was founded in 2006.

Where is Selenium's headquarters located?

Selenium's headquarters is located in Austin, TX, US.

When was Selenium's last funding round?

Selenium's most recent funding round was for $616k (USD) in March 2013.

How much has Selenium raised to-date?

As of Mar 7, 2013, Selenium has raised a total of $616k (USD).

How many employees does Selenium have?

Selenium has 31 employees as of Feb 4, 2024.

Selenium - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Device Coatings
  • Therapeutic Drugs
Tags
  • Biotech
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research